# Jama Cardiology > Use when targeting JAMA Cardiology or deciding whether a cardiovascular-medicine study fits this venue. Encodes the journal's fit, the cardiovascular-trial and outcomes evidence bar, reporting-guideline and trial-registration requirements, JAMA Network house style, official-submission re-check, and desk-reject heuristics. Venue-fit aid only, not clinical advice. - Skill: `thedixitjain/jama-cardiology` (Agent Skill) - Install (CLI): `npx skillmds add thedixitjain/jama-cardiology` - Raw SKILL.md: https://api.skillmd.com/api/skills/thedixitjain/jama-cardiology/raw - Safety review: pending - Works with: Claude Code, Claude.ai, OpenAI Codex - Category: Research & Search - Author: thedixitjain (https://skillmd.com/u/thedixitjain) - Updated: 2026-09-08 - Page: https://skillmd.com/skills/thedixitjain/jama-cardiology --- # JAMA Cardiology (jama-cardiology) ## Journal positioning JAMA Cardiology is a JAMA Network specialty journal for cardiovascular clinical research relevant to the practice of cardiology and cardiovascular medicine. It favors rigorous, practice-relevant work — randomized cardiovascular trials, large outcomes and registry analyses, prevention and risk-factor studies, and cardiac imaging studies tied to clinical outcomes — with JAMA's emphasis on hard endpoints, absolute risk, and direct relevance to patient care. Mechanistic bench cardiology, small physiology studies with surrogate-only readouts, and imaging-technique papers with no outcome link are a weak fit. This skill is a **fit / venue-selection / re-framing** aid; it is not clinical or regulatory advice and does not replace the journal's current instructions for authors. Before submitting, re-check the live JAMA Cardiology author instructions. ## When to trigger - The author names JAMA Cardiology for a cardiovascular clinical, outcomes, or imaging-outcome study and wants a fit/framing check. - A cardiovascular study must be re-framed around a hard clinical endpoint (MACE, mortality, hospitalization) for a practicing-cardiology audience. - The author is choosing between JAMA Cardiology, JAMA, and a cardiology-society journal. - The author needs the journal's reporting-guideline, registration, and desk-reject expectations for cardiovascular work. ## Scope & topic fit - Randomized cardiovascular trials (drug, device, procedural, or strategy) with clinically meaningful endpoints, including pragmatic and de-implementation designs. - Large outcomes, registry, and claims analyses on cardiovascular events, heart failure, arrhythmia, and structural/interventional outcomes. - Cardiovascular prevention, risk-factor, lipid, hypertension, and population cardiovascular-health studies. - Cardiac imaging (echo, CMR, CCT, nuclear) studies where the contribution is a clinical-outcome or prognostic association, not a pure imaging technique. - Cardiovascular biomarker and risk-prediction studies validated against outcomes. - Systematic reviews and meta-analyses answering a focused cardiovascular question. ## Method & evidence bar - Trials must be adequately powered with a prespecified primary endpoint, ideally a hard clinical outcome or validated composite (with the composite components reported); surrogate-only endpoints need strong justification. - The applicable reporting guideline and checklist are required: CONSORT for trials (with device/procedure extensions where relevant), STROBE for observational studies, PRISMA for systematic reviews; risk-model work should follow TRIPOD-style reporting. - Trials require prospective registration; registration number, protocol, and statistical-analysis plan are expected, including for device and procedural trials. - Effect estimates need absolute and relative measures, confidence intervals, adequate follow-up, and adjudicated endpoints where feasible. - Registry/observational claims must address confounding by indication, immortal-time bias, and missing data; causal language must match the design. - Risk-prediction and biomarker claims need internal and ideally external validation, calibration, and discrimination metrics. ## Structure & house style - JAMA Network format with a structured abstract and a Key Points box; re-check current article types (Original Investigation, Brief Report, Research Letter, etc.) and limits on the live guide. - The introduction frames a focused, practice-relevant cardiovascular question; the discussion states the clinical implication and absolute benefit/harm plainly. - Tables/figures follow JAMA Network statistical-reporting standards; CONSORT/STROBE flow diagrams, event-free survival curves with numbers at risk, and adjudicated-event tables are expected where applicable. - Supplements carry the protocol, SAP, endpoint definitions, and additional analyses. ## Official-submission checklist - Before giving submission-ready advice, read `../../resources/source-basis.md` and `../../resources/official-source-map.md`; start from the ICMJE and JAMA Network anchors, then cite the current JAMA Cardiology page you checked. - Search the live site for "JAMA Cardiology instructions for authors" and follow the current version. - Re-check article types and word/reference/table limits, structured-abstract and Key Points format, and the JAMA Network statistical-reporting requirements. - Confirm trial registration, the reporting checklist (CONSORT/STROBE/PRISMA), the data-sharing statement, and protocol/SAP submission. - Re-check IRB/ethics and consent statements, ICMJE authorship and conflict-of-interest disclosure (device/industry ties scrutinized), funding, and AI-use disclosure. - If the live official instructions conflict with this skill, the official instructions win. ## Pre-submission self-check - [ ] The study answers a practice-relevant cardiovascular question with a hard or validated clinical endpoint. - [ ] The primary endpoint is prespecified and adjudicated where feasible; the study is adequately powered. - [ ] The correct reporting checklist (CONSORT/STROBE/PRISMA/TRIPOD) is completed and attached. - [ ] Trials are prospectively registered with the number in the manuscript; protocol/SAP provided. - [ ] Confounding by indication, immortal-time bias, and missing data are addressed; causal language matches the design. - [ ] IRB/consent, ICMJE disclosures (including device/industry ties), and a data-sharing statement are prepared. ## Common desk-reject triggers - Underpowered trials or surrogate-only physiology studies framed as practice-relevant. - Imaging-technique papers with no clinical-outcome or prognostic link. - Registry/observational analyses with confounding by indication or immortal-time bias and overstated causal claims. - Risk models or biomarkers without validation, calibration, or discrimination reporting. - Missing trial registration, protocol, endpoint adjudication, or the required reporting checklist. - Mechanistic/basic cardiology better served by a cardiovascular-science journal. ## Re-routing decision - Broadly practice-changing, top-tier cardiovascular trial → general medicine (`jama` / NEJM / The Lancet in the natural-science bundle). - General internal-medicine relevance over cardiology specialty → `jama-internal-medicine`. - Cardiac imaging with an imaging-method core over clinical outcome → `radiology`. - Cerebrovascular/stroke-specific cardiovascular focus → `stroke`. - Surgical/perioperative cardiac focus → `jama-surgery`. ## Output format ```text [Fit] High / Medium / Low (one-line reason) [Target] JAMA Cardiology [Specialty tags] <2–3 closest cardiovascular topics> [Study design / reporting guideline] [Method/evidence] [Top risk] [Official items to re-check]
[Re-route suggestion] ``` --- **Source:** [`brycewang-stanford/Awesome-Journal-Skills`](https://github.com/brycewang-stanford/Awesome-Journal-Skills) → `Clinical-Medicine-Journal-Skills/skills/jama-cardiology/SKILL.md`